High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson’s disease
Abstract Combining high throughput screening approaches with induced pluripotent stem cell (iPSC)-based disease modeling represents a promising unbiased strategy to identify therapies for neurodegenerative disorders. Here we applied high content imaging on iPSC-derived neurons from patients with fam...
Main Authors: | Nasia Antoniou, Kanella Prodromidou, Georgia Kouroupi, Ioanna Boumpoureka, Martina Samiotaki, George Panayotou, Maria Xilouri, Ismini Kloukina, Leonidas Stefanis, Regis Grailhe, Era Taoufik, Rebecca Matsas |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-02-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-022-00278-y |
Similar Items
-
Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
by: Georgia Kouroupi, et al.
Published: (2020-09-01) -
MicroRNA-934 is a novel primate-specific small non-coding RNA with neurogenic function during early development
by: Kanella Prodromidou, et al.
Published: (2020-05-01) -
Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson’s Disease Patients
by: Maximilianos Elkouris, et al.
Published: (2019-02-01) -
Species-Specific miRNAs in Human Brain Development and Disease
by: Kanella Prodromidou, et al.
Published: (2019-12-01) -
Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson’s Disease
by: Elissavet Akrioti, et al.
Published: (2022-06-01)